CNBX Pharmaceuticals Inc. filed its 10-K on Nov 29, 2021 for the period ending Aug 31, 2021. In this report its auditor, Weinstein International CPA, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0107 USD | +12.22% | +2.88% | -24.65% |
1st Jan change | Capi. | |
---|---|---|
-24.65% | 333K | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- CNBX Stock
- News CNBX Pharmaceuticals Inc.
- CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt